Insect Allergen Extract - Honey Bee Venom, Yellow Jacket Venom, Paper Wasp Venom
Recommended ImmunologyUnrestrictedNot applicable line
Replacement supply of insect allergen extracts (bee venom, paper wasp venom, and yellow jacket venom) for immunotherapy, due to supply shortage of previously listed products.
1
Submissions
2016–16
On the record
—
ICER range
Cost-min
Cost basis
Access path
- Mar 2016Recommended
- PBS listing · Unrestricted
RecommendedDeferredNot recommended
From the public summary
PBAC outcome
3.1 The PBAC recommended listing the new forms of insect allergen extract-bee venom, insect allergen extract-paper wasp venom, and insect allergen extract-yellow jacket venom on the PBS on the basis of equivalent cost to the currently listed respective venom products.PSD · Mar 2016
3.2 The PBAC recommended that these new listings should be consistent with that for the currently listed venom products. 1PSD · Mar 2016
Cost-effectiveness
Cost-minimisation: listed on basis of equivalent cost to currently listed respective venom products; no formal ICER calculated.
The PBAC recommended listing the new forms of insect allergen extract-bee venom, insect allergen extract-paper wasp venom, and insect allergen extract-yellow jacket venom on the PBS on the basis of equivalent cost to the currently listed respective venom products. PBAC · 2016
Cost-effectiveness accepted
Decision context
PopulationPatients requiring insect allergen extracts (bee venom, paper wasp venom, yellow jacket venom) for immunotherapy.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Mar 2016 | Recommended | — | — | Cost-minimisation · Cost-minimisation |
Similar precedents
Insect Allergen Extract – Honey Bee Venom; Insect Allergen Extract – Paper Wasp Venom; Insect Allergen Extract – Yellow Jacket Venom93%Adrenaline (Epinephrine)61%Hepatitis B Surface Antigen Recombinant Vaccine59%Adrenaline55%House Dust Mite Allergen Extract53%Benralizumab53%Omalizumab52%Aciclovir52%
Regulatory · TGA
Label equal than PBS population — Both describe temporary replacement supply of identical insect venom extracts for immunotherapy during shortage.